Also trades as: 0R0H.L (LSE) · $vol 3M · TN8.DE (XETRA) · $vol 0M · TMO.TO (TSX) · $vol 0M · TMO.NE (NEO) · $vol 0M
TMO NYSE
Thermo Fisher Scientific Inc.
1W: +0.8%
1M: +2.1%
3M: +20.2%
YTD: +17.0%
1Y: +21.2%
3Y: +50.3%
5Y: +18.4%
$693.02
+8.13 (+1.19%)
Pre-Market: $695.27 (+2.25, +0.32%)
Weekly Expected Move ±4.1%
$619
$647
$674
$701
$729
Credit Risk of going bust: lower than 79% of companies Debt: 13.9% of company value Bonds: $454.1M held by 353 funds, 52 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $7.52 (down 99%), Thermo Fisher Scientific Inc. would be worth roughly what it owes.
Total debt $41.37B against a stock market value of $256.24B.
Distance to default 9.44 (Merton model): prices to 2026-10-27, balance sheet 2026-09-26, debt counted $21.82B (short-term plus half of long-term), stock volatility 29.2%; Altman Z'' 2.15. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $7.52 (down 99%), Thermo Fisher Scientific Inc. would be worth roughly what it owes.
Total debt $41.37B against a stock market value of $256.24B.
Distance to default 9.44 (Merton model): prices to 2026-10-27, balance sheet 2026-09-26, debt counted $21.82B (short-term plus half of long-term), stock volatility 29.2%; Altman Z'' 2.15. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
57 relationships49
As Filer
counterparties named
8
As Counterparty
mentioned by others
3
Rel. Types
2021-04-16
Earliest Filing
2026-02-12
Latest Filing
partner: 42
target: 5
acquirer: 2
Counterparties (Filed by TMO)
49 relationshipsCompanies named in TMO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| RBC Capital Markets, LLC | — | partner | Underwriter for the public offering of Senior Notes | 2026-02-12 | View |
| The Bank of New York Mellon Trust Company, N.A. | — | partner | Trustee for the Indenture governing the Senior Notes | 2026-02-12 | View |
| Clario Holdings, Inc. | — | target | Target of the announced acquisition | 2026-02-12 | View |
| Thermo Fisher International | TMO | partner | Indirect, wholly-owned finance subsidiary of Thermo Fisher Scientific Inc. that issued the Floating Rate and Fixed Rate | 2025-12-01 | View |
| Thermo Fisher Scientific Inc. | TMO | partner | Parent company that fully and unconditionally guaranteed the Notes on a senior unsecured basis. | 2025-12-01 | View |
| The Bank of New York Mellon Trust Company, N.A. | — | partner | Trustee under the Base Indenture and Supplemental Indenture governing the Notes. | 2025-12-01 | View |
| Barclays Bank PLC | TAPR | partner | Lead manager of the underwriters in the public offering of the Notes. | 2025-12-01 | View |
| BNP PARIBAS | — | partner | Lead manager of the underwriters in the public offering of the Notes. | 2025-12-01 | View |
| HSBC Continental Europe | — | partner | Lead manager of the underwriters in the public offering of the Notes. | 2025-12-01 | View |
| Morgan Stanley & Co. International plc | MS-PL | partner | Lead manager of the underwriters in the public offering of the Notes. | 2025-12-01 | View |
| Wilmer Cutler Pickering Hale and Dorr LLP | — | partner | U.S. counsel to the Company and Thermo Fisher International regarding the legality of the Securities. | 2025-12-01 | View |
| Linklaters LLP | — | partner | Dutch counsel to Thermo Fisher International regarding the Notes. | 2025-12-01 | View |
| Moody's Investors Service, Inc. | — | partner | Rating agency referenced in the change of control provision for the Notes. | 2025-12-01 | View |
| S&P Global Ratings | SPGI | partner | Rating agency referenced in the change of control provision for the Notes. | 2025-12-01 | View |
| Fitch Ratings Limited | — | partner | Rating agency referenced in the change of control provision for the Notes. | 2025-12-01 | View |
| The Bank of New York Mellon Trust Company, N.A. | — | partner | Serves as trustee under the Base Indenture and Supplemental Indenture for the Senior Notes. | 2025-10-07 | View |
| ING Financial Markets LLC | — | partner | Acted as a representative underwriter in the public offering of the Senior Notes. | 2025-10-07 | View |
| Scotia Capital (USA) Inc. | — | partner | Acted as a representative underwriter in the public offering of the Senior Notes. | 2025-10-07 | View |
| Morgan Stanley & Co. LLC | MS-PL | partner | Acted as a representative underwriter in the public offering of the Notes. | 2023-12-05 | View |
| The Bank of New York Mellon Trust Company, N.A. | — | partner | Serves as trustee under the Indenture for the Senior Notes. | 2023-12-05 | View |
| U.S. Bancorp Investments, Inc. | — | partner | Acted as a representative underwriter in the public offering of the Notes. | 2023-12-05 | View |
| Moody's Investors Service, Inc. | — | partner | Credit rating agency referenced in the change of control provisions. | 2023-12-05 | View |
| S&P Global Ratings | SPGI | partner | Credit rating agency referenced in the change of control provisions. | 2023-12-05 | View |
| Fitch Ratings, Limited | — | partner | Credit rating agency referenced in the change of control provisions. | 2023-12-05 | View |
| Wilmer Cutler Pickering Hale and Dorr LLP | — | partner | Provided legal opinion regarding the Notes. | 2023-12-05 | View |
| The Bank of New York Mellon Trust Company, N.A. | — | partner | Serves as trustee under the Base Indenture and Supplemental Indenture for the Senior Notes. | 2023-08-10 | View |
| Citigroup Global Markets Inc. | — | partner | Acted as a representative underwriter in the public offering of the Senior Notes. | 2023-08-10 | View |
| Goldman Sachs & Co. LLC | GSCE | partner | Acted as a representative underwriter in the public offering of the Senior Notes. | 2023-08-10 | View |
| The Bank of New York Mellon Trust Company, N.A. | — | partner | Trustee for the Euro and USD Indentures | 2022-11-21 | View |
| Moody's Investors Service, Inc. | — | partner | Credit rating agency | 2022-11-21 | View |
| S&P Global Ratings | SPGI | partner | Credit rating agency | 2022-11-21 | View |
| Fitch Ratings, Limited | — | partner | Credit rating agency | 2022-11-21 | View |
| Citigroup Global Markets Limited | — | partner | Underwriter for Euro Offering | 2022-11-21 | View |
| Deutsche Bank AG, London Branch | — | partner | Underwriter for Euro Offering | 2022-11-21 | View |
| Merrill Lynch International | IPB | partner | Underwriter for Euro Offering | 2022-11-21 | View |
| Citigroup Global Markets Inc. | — | partner | Underwriter for USD Offering | 2022-11-21 | View |
| Wilmer Cutler Pickering Hale and Dorr LLP | — | partner | Legal counsel for the Company | 2022-11-21 | View |
| PPD, Inc. | PPD | target | Target of the Company's announced acquisition. | 2021-11-18 | View |
| Citigroup Global Markets Europe AG | — | partner | Lead manager of the underwriting agreement for the new notes offering. | 2021-11-18 | View |
| Morgan Stanley Europe SE | MS-PL | partner | Lead manager of the underwriting agreement for the new notes offering. | 2021-11-18 | View |
| Barclays Bank PLC | TAPR | partner | Lead manager of the underwriting agreement for the new notes offering. | 2021-11-18 | View |
| PPD, Inc | — | target | Target company in the acquisition for which the net proceeds from the notes offering are intended to be used. | 2021-10-18 | View |
| Morgan Stanley & Co. LLC | MS-PL | partner | Underwriter in the offering of Senior Notes | 2021-08-23 | View |
| PPD, Inc | — | target | Target of the announced acquisition | 2021-08-23 | View |
| Barclays Capital Inc. | BCLYF | partner | Underwriter in the offering of Senior Notes | 2021-08-23 | View |
| Citigroup Global Markets Inc. | — | partner | Underwriter in the offering of Senior Notes | 2021-08-23 | View |
| Thermo Fisher Scientific Inc. | TMO | acquirer | Parent company acquiring PPD, Inc. in a merger transaction. | 2021-04-16 | View |
| Powder Acquisition Corp. | PODD | acquirer | Special purpose acquisition company (SPAC) merging with PPD, Inc. | 2021-04-16 | View |
| PPD, Inc. | PPD | target | Target company being acquired by Powder Acquisition Corp. and Thermo Fisher Scientific Inc. | 2021-04-16 | View |
Mentioned As Counterparty
8 mentionsOther companies that named TMO in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | partner | Parent company of Patheon Manufacturing Services LLC. | 2025-09-30 | View |
| SOLV Solventum Corp | target | Acquired Solventum's purification and filtration business for approximately $4.0 billion in cash. | 2025-09-02 | View |
| HRTX HERON THERAPEUTICS, INC. /DE/ | partner | Named party in Framework Agreement for unspecified purposes | 2025-08-12 | View |
| SOLV Solventum Corp | target | Agreed to acquire Solventum's purification and filtration business assets and liabilities. | 2025-06-25 | View |
| SOLV Solventum Corp | target | Acquiring Solventum's purification and filtration business for approximately $4.10 billion | 2025-02-27 | View |
| IMDX Oncocyte Corp | partner | Parent company of Life Technologies Corporation listed as notice recipient | 2023-02-13 | View |
| PTPI Petros Pharmaceuticals, Inc. | partner | Parent company of Patheon Pharmaceuticals Inc. | 2022-01-24 | View |
| IMDX Oncocyte Corp | partner | Entered into a collaboration with Oncocyte to expand access to precision oncology through co-development and co-marketin | 2022-01-18 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-21 | Earnings Release; Exhibits | View | |
| 2026-07-23 | Earnings Release; Exhibits | View | |
| 2026-05-26 | Shareholder Vote | View | |
| 2026-04-23 | Earnings Release; Exhibits | View | |
| 2026-03-24 | Other Events; Exhibits | View | |
| 2026-02-12 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-01-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-12 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-01 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-10-29 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-22 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-07 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-09-02 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-23 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-05-28 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-22 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-25 | Other Events | View | |
| 2025-02-19 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR